← Leaderboards
Joseph H Korn
Boston University Medical Campus
$868,449
Attributed
$868,449
Total exposure
12
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.7K · FY2005–06$10K$7.5K$5K$2.5K$0
'05
'06
Funding mix
By agency
NIH$868,449 · 12
By mechanism
R01$536,807 · 2
T32$291,915 · 1
R13$20,000 · 1
M01$19,727 · 8
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Michael D Stein$43,083,732
- Jeffrey H Samet$129,777,857
- Darrell N. Kotton$37,875,782
- Robert A Lafyatis$10,905,922
- Douglas V Faller$14,088,389
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchSystemic SclerodermaTissue /Cell CultureCollagenSclerodermaHuman Therapy EvaluationFibroblastsPolymerase Chain ReactionTranscription FactorDrug Administration Rate /DurationCollagenaseIn Situ HybridizationImmunologic Skin TestSkin Disorder ChemotherapyGene ExpressionBiopsyGel Mobility Shift AssayImmunocytochemistryConnective Tissue Disorder DiagnosisConnective Tissue Disorder ChemotherapyCell Growth RegulationEnzyme ActivityBlood Tests
Grant awards (19)
IMMUNE MEDIATED ALTERATIONS IN BLOOD$386
M01 · FY2006 · RR · contact PI
ORAL TYPE 1 BOVINE COLLAGEN IN SCLERODERMA$386
M01 · FY2006 · RR · contact PI
INTERFERON B-7A IN THE TREATMENT OF SYSTEMIC SCLERODERMA$3,315
M01 · FY2005 · RR
ORAL TYPE 1 BOVINE COLLAGEN IN SCLERODERMA$1,842
M01 · FY2005 · RR
IMMUNE MEDIATED ALTERATIONS IN CONNECTIVE TISSUE$1,473
M01 · FY2005 · RR
IMMUNE MEDIATED ALTERATIONS IN BLOOD$737
M01 · FY2005 · RR
MONOCLONAL ANTIBODY IN PATIENTS WITH SYSTEMIC SCLEROSIS$377
M01 · FY2005 · RR
Rheumatology Training Grant$181,822
T32 · FY2004 · AR
Oral Type 1 Bovine Collagen in Scleroderma$5,786
M01 · FY2004 · RR
Immune Mediated Alterations in Connective Tissue$3,255
M01 · FY2004 · RR
Immune Mediated Alterations in Blood$1,446
M01 · FY2004 · RR
Interferon B-7a in the Treatment of Systemic Scleroderma$724
M01 · FY2004 · RR
DIFFERENTIAL GENE EXPRESSION IN SCLERODERMA FIBROBLASTS$237,165
R01 · FY2002 · AR
International Workshop for Scleroderma Research$20,000
R13 · FY2002 · AR
RHEUMATOLOGY TRAINING GRANT$42,899
T32 · FY2001 · AR
RELAXIN THERAPY IN SUBJECTS WITH SYSTEMIC SCLEROSIS WITH DIFFUSE SCLERODERMA$0
M01 · FY2001 · RR
IMMUNE MEDIATED ALTERATIONS IN CONNECTIVE TISSUE$299,642
R01 · FY2000 · AR
RHEUMATOLOGY TRAINING GRANT$67,194
T32 · FY2000 · AR
RELAXIN THERAPY--SYSTEMIC SCLEROSIS W/ DIFFUSE SCLERODER$0
M01 · FY2000 · RR